Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GigaVax ApS
APS
Active
CVR 41855495
Kong Valdemars Vej 16
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2020
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -8K
-62% vs 2023
EBITDA margin
100.0%
+62% vs 2023
Equity ratio
-33.3%
Financial strength
Net profit 2024
DKK -14K
+13% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -8K
-62%
EBITDA
DKK -8K
+62%
Net profit
DKK -14K
+13%
Total assets
DKK 268K
+41%
Equity
DKK -89K
-18%
Employees
—
—
Company information
Legal name
GigaVax ApS
CVR number
41855495
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. november 2020
Share capital
DKK 60.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og et medlem af bestyrelsen i forening.
Company purpose
Selskabets formål er at udvikle og forhandle analytiske og diagnostiske tests samt vacciner, samt dermed beslægtet virksomhed
Contact
Address
Kong Valdemars Vej 16
Phone
+4529203336
Email
dottore.k@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Rudersdal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Revenue
-32
-88
-20
-8
Staff expenses
-0
-0
-0
-0
EBITDA
-32
-88
-20
-8
Depreciation & amort.
-0
-0
-0
-0
EBIT
-32
-88
-20
-8
Net financials
-0
-7
0
-10
Profit before tax
-33
-95
-20
-18
Tax
-7
-21
-5
-4
Net profit
-25
-74
-16
-14
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
26
132
190
268
Equity
15
-59
-75
-89
Long-term debt
0
0
0
0
Short-term debt
12
192
265
357
Total debt
12
192
265
357
Financial ratios
5-year trend
EBITDA margin
-769000.0%
This company
15.8%
Market median
-4867189% vs market
2021
2024
Equity ratio
-33.3%
This company
38.2%
Market median
-187% vs market
2021
2024
Return on equity
-1384900.0%
This company
18.4%
Market median
-7526730% vs market
2021
2024
Net profit margin
-1384900.0%
This company
8.1%
Market median
-17097631% vs market
2021
2024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
2021
2024
Debt / equity
4.00×
This company
0.62×
Market median
-545% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-11-16 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
KA
Kenn Axø Gerdes
Management
Management
2020
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
HP
Henrik Pedersen
Chairman
2020
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Fwd Holding ApS
Company
50.0%
50.0%
2025
SCIENT. INVEST ApS
Company
33.3%
33.3%
2025
Hans-Henrik Kristensen
Individual
5.0%
5.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Fwd Holding ApS
GigaVax ApS
(this company)
Board network connections
Board members of GigaVax ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Kenn Axø Gerdes
Management
0 companies
Henrik Pedersen
Chairman
0 companies